DIGITAL-COOPERATION
The Digital Cooperation Organization (DCO), a global multilateral organization committed to enabling digital prosperity for all by accelerating the sustainable and inclusive growth of the digital economy, announced the launch of EconomiX magazine, a publication offering insights from international digital economy thought leaders into ways nations and organizations can seize the digital economy’s opportunities to spur digital transformation globally. By merging insights from different stakeholders from the public and private sectors, academia, and international organizations from DCO Member States and other countries, EconomiX provides a holistic view of the digital economy from different perspectives.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240527424476/en/
1st Issue of the “EconomiX by the DCO” magazine (Graphic: AETOSWire)
The first edition of EconomiX covers a wide range of topics including global news on the digital economy, updates from DCO Member States, special articles on "Developing new AI business models" and "Digital upskilling -future-proof jobs". The theme of the magazine's first issue "Growth Unleashed - AI: Powering Economic Prosperity" delves into the world of artificial intelligence and its transformative impact on economies worldwide.
In addition to exclusive interviews with H.E. Dr. Bosun Tijani, Minister of Communications, Innovation and Digital Economy of the Federal Republic of Nigeria, and H.E. Paula Ingabire, Minister of Information and Communications Technology and Innovation of the Republic of Rwanda, and Ms. Deemah AlYahya, Secretary-General of the DCO, this issue features articles and interviews with a distinguished group of ministers, CEOs, and experts in technology and the digital economy.
Manel Bondi, DCO’s Chief of Digital Markets Growth, commented: "EconomiX stands as a catalyst for change and empowerment amidst the digital revolution. It fills an important gap with its focus on the economic dimension of technology as a key pillar to drive and sustain inclusive and meaningful economic growth across the globe. It demonstrates how communities, businesses, and governments can cooperate meaningfully and pave the way toward achieving digital prosperity for all. EconomiX is a platform that fosters knowledge sharing, innovation, and inspiration for our readers, and reflects our dedication to promoting cooperation to develop the global digital economy."
Addressing critical aspects of digital economic advancement like policy making, data transformation, digital updates, women empowerment, and thought leadership, EconomiX endeavors to guide its readers through the digital revolution. It aims to provide actionable insights, expert analysis, and case studies for navigating digital change, fostering an understanding of how to leverage digital transformation for economic and social prosperity.
The magazine is a vital tool for digital transformation, aimed at empowering change by fostering knowledge exchange, enhancing cooperation, uplifting social prosperity, and stimulating innovation. It presents global trends and innovations, advocates for inclusive digital transformation, and fosters a community of leaders shaping the digital future. It also highlights the DCO's impactful initiatives and showcases success stories from the network. Available in both digital and print formats, it is an invaluable resource for those committed to making a significant impact in the digital realm. https://www.dco.org/economix
Source: AETOSWire
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240527424476/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies8.12.2025 00:00:00 CET | Press release
Novel BCL2 inhibitor sonrotoclax monotherapy demonstrates deep and durable clinical responses in R/R MCL and R/R CLLSonrotoclax in combination with BRUKINSA demonstrated rapid MRD negativity in treatment-naive CLL, regardless of high-risk features BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data on sonrotoclax, a next-generation investigational BCL2 inhibitor, demonstrating meaningful clinical benefit as monotherapy and in combination across B-cell malignancies. These data were featured at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition in Orlando, Florida. The five presentations highlight durable responses in heavily pretreated patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL) and additional studies showing deep, rapid, and sustained undetectable minimal residual disease (uMRD) rates with sonrotoclax-based combinations in patients with treatment-naive chronic lymphocytic leukemi
Andersen Consulting tilføjer samarbejdsfirmaet Codezilla7.12.2025 21:19:00 CET | Pressemeddelelse
Andersen Consulting styrker sine kompetencer inden for digital transformation gennem en samarbejdsaftale med Codezilla, et firma med hovedsæde i Rumænien, der udvikler specialtilpasset software. Codezilla specialiserer sig i at udvikle skræddersyede softwareprodukter, der løser forretningsmæssige udfordringer gennem en tværfaglig tilgang, som kombinerer softwareudvikling med dybdegående marketingekspertise. Med over 30 år på markedet fungerer firmaet som implementerings- og digital konsulentressource for reklamebureauer, samtidig med at de arbejder med en bred kundebase, herunder virksomheder inden for sundhedssektoren og medicinsk udstyr. Codezillas interne teams strækker sig over teknik, design og strategi og leverer omnichannel-løsninger til både regionale og globale kunder. "Vi tror på, at fantastisk software er resultatet af solid ingeniørkunst og disciplineret eksekvering," udtaler Sebastian Doroftei, administrerende direktør for Codezilla. "Vores samarbejde med Andersen Consulti
Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 17:00:00 CET | Press release
AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th
CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 13:00:00 CET | Press release
Summit debuts Mayors in Motion initiative and CoMotion Urban Visionary Distinction as Riyadh showcases its rise as global mobility testbed Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
